In Reply to Drs. Cheung and Schulz and Kagan

[1]  Alexandra L Hanlon,et al.  What dose of external-beam radiation is high enough for prostate cancer? , 2007, International journal of radiation oncology, biology, physics.

[2]  Alexandra L Hanlon,et al.  Radiation dose and late failures in prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[3]  Yoshiya Yamada,et al.  Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. , 2006, The Journal of urology.

[4]  Tom W J Scheenen,et al.  IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. , 2006, International journal of radiation oncology, biology, physics.

[5]  C. Ma,et al.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. , 2006, International journal of radiation oncology, biology, physics.

[6]  A. Hanlon,et al.  The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer , 2004, Cancer.

[7]  Patrick A. Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. , 2007, International journal of radiation oncology, biology, physics.

[8]  A. Hanlon,et al.  Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[9]  B Pickett,et al.  Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. , 2001, International journal of radiation oncology, biology, physics.

[10]  C C Ling,et al.  Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.

[11]  L Verhey,et al.  Static field intensity modulation to treat a dominant intra-prostatic lesion to 90 Gy compared to seven field 3-dimensional radiotherapy. , 1999, International journal of radiation oncology, biology, physics.

[12]  E. Horwitz,et al.  The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer , 2008, Cancer.

[13]  A. Hanlon,et al.  Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. , 2003, International journal of radiation oncology, biology, physics.